Friday, May 1, 2026

North Korea Uses Kim Il Sung’s Birthday to Cement Kim Jong Un’s Grip on Power

North Korea celebrates Kim Il Sung's 113th birthday, emphasizing loyalty to Kim Jong Un and his revolutionary achievements and plans.

USD-KRW Exchange Rate Nears 1,480: What Does This Mean for Your Investments?

USD-KRW exchange rate nears 1,480 KRW as U.S.-Iran negotiation hopes fade, driven by rising oil prices and market uncertainty.

New Class 4 Disease Regulations on Candida Auris Starting March 29 in South Korea

KDCA classifies Candida auris as a Class 4 infectious disease, enhancing surveillance and management to combat this resistant pathogen.

Tag: biopharmaceuticals

North KoreaKoreaKimMilitarySouth KoreaAImarketrelationsInternational

Microgravity in Space May Revolutionize How Biopharmaceuticals Form and Function within the Body

Space's microgravity could transform biopharmaceuticals, enabling new treatments and technologies for diseases, emphasizing long-term research.

Samsung Bioepis Launches AI Academy: How 1,000 Employees Will Master AI by July 2026

Samsung Bioepis launches an AI training program for employees to enhance skills in biopharmaceuticals, boosting global competitiveness.

How SK Life Science is Bridging Communication Gaps in Epilepsy Management

SK Life Science will present findings on epilepsy treatment and patient-provider communication at the 2026 AAN Annual Meeting in Chicago.

Pangen Expands Cell-Based Bioassay Services for Customized Drug Development

Pangen is expanding its cell-based activity analysis services after a new contract, enhancing drug evaluation capabilities for various medications.

Samsung Biologics Wins “Sustainability Leadership” at CDMO Awards: What This Means for the Future of Biopharma

Samsung Biologics wins the Sustainability Leadership award, marking a 13-year streak and highlighting its commitment to sustainable practices.

Samsung Biologics America Achieves Record Profit: What This Means for Global Expansion in 2026

Samsung Biologics America reports record profits, showcasing its successful global expansion strategy despite previous revenue dips.

Lotte Biologics Wins CDMO Leadership Award… Validates “Quality Management”

Lotte Biologics wins "Best New or Relaunched CDMO" at the 2026 CDMO Leadership Awards, showcasing rapid growth and global recognition.

Alteogen and Biogen: A Game-Changing 200 Million USD License Deal for ALT-B4 Biopharmaceuticals

Alteogen partners with Biogen for exclusive licensing of subcutaneous biopharmaceuticals, potentially earning up to 549 million USD.

Samsung Biologics Strengthens Global Partnerships at Decat Week 2026: Key Insights and Strategies

Samsung Biologics aims to enhance global partnerships at J.P. Morgan's Healthcare Conference 2026, showcasing its CDMO strengths.

Samsung Biologics CEO John Rim Poised for Third Term: What This Means for the Global CDMO Market in 2026

John Rim of Samsung Biologics aims for a third term, leading record growth and expansion into next-gen therapies amid global challenges.

Dongkoo Bio&Pharma Invests 1 Billion KRW in GenomAndCompany: What This Means for ADC Drug Development

Dongkoo Bio&Pharma invests 1 billion KRW in Genome & Company to enhance antibody and ADC drug development strategies.

Celltrion’s Strategic Move: How Local Production in the U.S. Can Mitigate Tariff Risks

Celltrion outlines its Branchburg facility's operations and plans to mitigate tariff risks by establishing local production and a supply system.

Samsung Biologics: How a 56 Billion USD CDMO Leader is Shaping the Future of Biopharmaceuticals

Samsung Biologics is evolving as a leading CDMO, targeting a production capacity of 1.32M liters by 2030 after its spin-off from Bioepis.

How ABL Bio’s Grabody-B Revolutionizes siRNA Delivery: A Game-Changer for Brain Disease Treatment?

ABL Bio's Grabody-B technology effectively delivers siRNA across the blood-brain barrier, enhancing treatment for brain and systemic diseases.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.